<DOC>
	<DOCNO>NCT01740479</DOCNO>
	<brief_summary>To determine whether , background optimal medical therapy , include ticagrelor , open suitable narrowing blockage find time primary PCI acute heart attack well treat culprit lesion patient multi-vessel disease .</brief_summary>
	<brief_title>Complete v Culprit-only Revascularization Treat Multi-vessel Disease After Primary PCI STEMI</brief_title>
	<detailed_description>To determine whether , background optimal medical therapy low-dose ASA ticagrelor , strategy complete revascularization involve stag PCI use drug elute stent suitable non-infarct related artery lesion superior strategy culprit lesion-only revascularization reduce composite outcome CV death MI patient multi-vessel disease undergone successful culprit lesion primary PCI STEMI .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>1 . Men woman within 72 hour successful PCI ( preferably use drug elute stent ) culprit lesion STEMI . PCI STEMI either primary PCI rescue PCI fail fibrinolysis combination strategy PCI perform routinely 312 hour fibrinolysis AND 2 . Multivessel disease define least 1 additional noninfarct relate coronary artery lesion least 2.5 mm diameter stented part primary PCI amenable successful treatment PCI : At least 70 % diameter stenosis ( visual estimation ) At least 50 % diameter stenosis ( visual estimation ) fractional flow reserve ( FFR ) â‰¤ 0.80 1 . Planned revascularization nonculprit lesion 2 . Planned surgical revascularization 3 . Noncardiovascular comorbidity reduce life expectancy &lt; 5 year 4 . Any factor preclude 5 year followup 5 . Prior Coronary Artery Bypass Graft ( CABG ) Surgery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>STEMI</keyword>
	<keyword>ticagrelor</keyword>
	<keyword>multi-vessel disease</keyword>
	<keyword>culprit lesion</keyword>
</DOC>